Glaucoma Market Size, Free PDF, Growth, Trends & Forecast to US$ 12.77 Billion By 2031 | Leading Companies - Thea Pharma Inc., Pfizer Inc., Santen Pharmaceutical Co., Ltd., Sun Pharmaceutical Industries, Inc., Somerset Pharma LLC

DataM Intelligence unveils its latest report on the "Glaucoma Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential for companies aiming to stay ahead in the competitive Market.

Furthermore, the higher prevalence of glaucoma in the region is a key driver of market growth. For example, the Centers for Disease Control and Prevention (CDC) reports that glaucoma is a leading cause of blindness in the U.S., with current cases totaling around 3 million and projected to rise to approximately 6.3 million by 2050.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/glaucoma-market?kb

Growth Drivers

The glaucoma market is poised for significant growth in the coming years, driven by the increasing prevalence of the condition, particularly among the elderly population. Glaucoma primarily affects individuals over 60, and with the global population aging, the risk of developing the disease continues to rise. Currently, there are an estimated 80 million glaucoma patients worldwide, and projections indicate that by 2040, around 22 million people could be blind due to glaucoma. The aging demographic, expected to reach 1.42 billion by 2030, further underscores this trend. Epidemiological studies suggest that by 2040, the total number of glaucoma cases worldwide could reach approximately 112 million. As prevalence increases, the demand for advanced therapeutics is expected to grow steadily, fueling market expansion.

Furthermore, manufacturers are increasingly focusing on this class of medications due to their proven effectiveness in glaucoma management. For example, in December 2024, the U.S. Food and Drug Administration (FDA) approved iDoseTR, a travoprost intracameral implant developed by Glaukos Corporation. iDoseTR is a long-acting intracameral therapy designed to provide continuous delivery of prostaglandin at therapeutic levels.

For example, the American Academy of Ophthalmology reports that primary open-angle glaucoma (POAG) affects approximately 1.86% of individuals over 40 years of age. The prevalence of POAG is highest among Chinese populations, intermediate among Japanese, and lower among Europeans and Indians. In a population-based study in rural East Africa, 3,268 participants underwent eye examinations, revealing a POAG prevalence of 3.1%. Similarly, a hospital-based survey in Ghana found that primary open-angle glaucoma was the most common type, accounting for 44.2% of cases.

Additionally, market players derive a significant portion of their revenue from the region, contributing to its market dominance. For example, AbbVie reported USD 432 million in revenue in 2023 for Lumigan (bimatoprost), with nearly 40% coming from the U.S. market. In the same year, the company earned USD 272 million from Alphagan, a treatment for open-angle glaucoma, with approximately 45% of this revenue generated in the U.S.

Key Players

Novartis AG, Bausch + Lomb., Viatris Inc., AbbVie., Alcon Inc., Thea Pharma Inc., Pfizer Inc., Santen Pharmaceutical Co., Ltd., Sun Pharmaceutical Industries, Inc., Somerset Pharma LLC among others.

Emerging Players

Metcela Inc., Inspira-Technologies OXY B.H.N. LTD., LIVANOVA PLC among others.

Forecast Projection:

The Global Glaucoma Market is poised for significant growth between 2025 and 2032. In 2024, the market maintained a steady upward trajectory, and with strategic initiatives by leading players accelerating adoption, the market is expected to soar throughout the forecast period. Companies leveraging these trends are well-positioned to capture emerging opportunities and maximize revenue potential.

Market Intelligence Research Process:

The Glaucoma Market research report by DataM Intelligence combines primary and secondary data to deliver deep, actionable insights. It examines the full spectrum of factors shaping the industry, from government regulations and market conditions to competitive dynamics, historical trends, technological breakthroughs, upcoming innovations, and potential challenges. This comprehensive analysis not only highlights growth prospects but also identifies barriers, equipping businesses to navigate market volatility and capitalize on emerging opportunities.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=glaucoma-market

Key Segmentation:

By Type: (Open-Angle Glaucoma, Angle-Closure Glaucoma, Congenital Glaucoma, Others)

By Treatment Type: (Prostaglandins, Beta Blockers, Alpha-Adrenergic Agonists, Carbonic Anhydrase Inhibitors, Miotics, Rho Kinase Inhibitors, Implants, Others)

By Age Group: (Children, Adults, Geriatrics)

By Distribution Channel: (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

Global Growth Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1 - Market Overview: Kickstarts the report with a comprehensive snapshot of the Glaucoma Market, summarizing key segments by region, product type, and application. Highlights include market size, segment growth potential, and short- & long-term industry outlook.

Chapter 2 - Emerging Trends: Uncovers the game-changing trends and high-impact innovations shaping the future of the industry.

Chapter 3 - Competitive Landscape: Offers a deep dive into market competition, detailing revenue shares, strategic initiatives, and recent mergers & acquisitions.

Chapter 4 - Top Player Profiles: Features detailed company profiles, covering revenue, profit margins, product lines, and major milestones for leading market players.

Chapters 5 & 6 - Regional & Country Analysis: Breaks down revenue performance across global regions, providing insights on market sizes, opportunities, and growth prospects worldwide.

Chapter 7 - Segmentation Analysis: Explores market segmentation by type, revealing high-potential categories and guiding businesses towards lucrative areas.

Chapter 8 - Application Insights: Examines downstream markets and identifies promising sectors for expansion, showing how different applications are driving growth.

Chapter 9 - Supply Chain Mapping: Maps the entire industry supply chain, highlighting upstream and downstream activities for a holistic market perspective.

Chapter 10 - Key Takeaways: Concludes with critical insights and actionable strategies, equipping stakeholders to make informed decisions and stay ahead in the market.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/glaucoma-market?kb

FAQ's

Q1: What is the current size of the Glaucoma Market and its future potential?

A: The Glaucoma Market was valued at US$ 8.36 billion in 2023 and is projected to surge to US$ 12.77 billion by 2031

Q2: How fast is the Glaucoma Market expected to grow in the coming years?

A: The market is forecast to expand at a robust CAGR of 5.5% between 2025 and 2032, signaling strong global growth and investment potential.

Q3: Which regions are dominating the Glaucoma Market and which are fastest-growing?

A: North America dominating the Glaucoma market.

Request 2 Days Free Trials with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?kb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.